Alpha 2.0
Login Register
» Articles » PMID: 28135358

Important Questions About Lung Cancer Screening Programs When Incidental Findings Exceed Lung Cancer Nodules by 40 to 1

Overview
Journal JAMA Intern Med
Publisher American Medical Association
Specialty General Medicine
Date 2017 Jan 31
PMID 28135358
Citations 4
Authors
Rita F Redberg
Patrick G OMalley
Affiliations
Soon will be listed here.
Citing Articles

Serum exosomal small nucleolar RNA (snoRNA) signatures as a predictive biomarker for benign and malignant pulmonary nodules.

Cao F, You Q, Zhu F, Zhang Y Cancer Cell Int. 2024; 24(1):341.

PMID: 39402628 PMC: 11475846. DOI: 10.1186/s12935-024-03522-y.

Assessment of Lung Cancer Screening Program Websites.

Clark S, Reuland D, Enyioha C, Jonas D JAMA Intern Med. 2020; 180(6):824-830.

PMID: 32282024 PMC: 7154949. DOI: 10.1001/jamainternmed.2020.0111.

A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.

Kossenkov A, Qureshi R, Dawany N, Wickramasinghe J, Liu Q, Majumdar R Cancer Res. 2018; 79(1):263-273.

PMID: 30487137 PMC: 6317999. DOI: 10.1158/0008-5472.CAN-18-2032.

Using the New CellCollector to Capture Circulating Tumor Cells from Blood in Different Groups of Pulmonary Disease: A Cohort Study.

He Y, Shi J, Shi G, Xu X, Liu Q, Liu C Sci Rep. 2017; 7(1):9542.

PMID: 28842574 PMC: 5572713. DOI: 10.1038/s41598-017-09284-0.